Empire Company Limited
Empire Company Limited (EMLAF) Stock Competitors & Peer Comparison
See (EMLAF) competitors and their performances in Stock Market.
Peer Comparison Table: Grocery Stores Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| EMLAF | $36.29 | +3.39% | 8.4B | 16.72 | $2.17 | +1.71% |
| LBLCF | $49.24 | -2.03% | 58.2B | 32.83 | $1.50 | +0.81% |
| TSCDY | $20.46 | +0.54% | 44.3B | 21.98 | $0.93 | +2.71% |
| TSCDF | $6.84 | +5.39% | 43.5B | 22.06 | $0.31 | +2.77% |
| AHODF | $48.92 | +1.92% | 43.4B | 16.47 | $2.97 | +2.75% |
| ADRNY | $48.73 | +0.06% | 43.1B | 16.42 | $2.96 | +2.78% |
| SVNDF | $14.50 | -6.45% | 34.5B | 23.39 | $0.62 | +2.09% |
| SVNDY | $14.42 | +1.55% | 34.3B | 23.24 | $0.62 | +1.06% |
| WNGRF | $72.62 | -0.33% | 27.8B | 26.41 | $2.75 | +1.16% |
| WOLWF | $20.94 | +0.00% | 25.6B | 38.07 | $0.55 | +2.59% |
Stock Comparison
EMLAF vs LBLCF Comparison February 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.4B. In comparison, LBLCF has a market cap of 58.2B. Regarding current trading prices, EMLAF is priced at $36.29, while LBLCF trades at $49.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 16.72, whereas LBLCF's P/E ratio is 32.83. In terms of profitability, EMLAF's ROE is +0.12%, compared to LBLCF's ROE of +0.22%. Regarding short-term risk, EMLAF is less volatile compared to LBLCF. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check LBLCF's competition here
EMLAF vs TSCDY Comparison February 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.4B. In comparison, TSCDY has a market cap of 44.3B. Regarding current trading prices, EMLAF is priced at $36.29, while TSCDY trades at $20.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 16.72, whereas TSCDY's P/E ratio is 21.98. In terms of profitability, EMLAF's ROE is +0.12%, compared to TSCDY's ROE of +0.14%. Regarding short-term risk, EMLAF is less volatile compared to TSCDY. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check TSCDY's competition here
EMLAF vs TSCDF Comparison February 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.4B. In comparison, TSCDF has a market cap of 43.5B. Regarding current trading prices, EMLAF is priced at $36.29, while TSCDF trades at $6.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 16.72, whereas TSCDF's P/E ratio is 22.06. In terms of profitability, EMLAF's ROE is +0.12%, compared to TSCDF's ROE of +0.14%. Regarding short-term risk, EMLAF and TSCDF have similar daily volatility (0.00).Check TSCDF's competition here
EMLAF vs AHODF Comparison February 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.4B. In comparison, AHODF has a market cap of 43.4B. Regarding current trading prices, EMLAF is priced at $36.29, while AHODF trades at $48.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 16.72, whereas AHODF's P/E ratio is 16.47. In terms of profitability, EMLAF's ROE is +0.12%, compared to AHODF's ROE of +0.16%. Regarding short-term risk, EMLAF and AHODF have similar daily volatility (0.00).Check AHODF's competition here
EMLAF vs ADRNY Comparison February 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.4B. In comparison, ADRNY has a market cap of 43.1B. Regarding current trading prices, EMLAF is priced at $36.29, while ADRNY trades at $48.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 16.72, whereas ADRNY's P/E ratio is 16.42. In terms of profitability, EMLAF's ROE is +0.12%, compared to ADRNY's ROE of +0.16%. Regarding short-term risk, EMLAF is less volatile compared to ADRNY. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check ADRNY's competition here
EMLAF vs SVNDF Comparison February 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.4B. In comparison, SVNDF has a market cap of 34.5B. Regarding current trading prices, EMLAF is priced at $36.29, while SVNDF trades at $14.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 16.72, whereas SVNDF's P/E ratio is 23.39. In terms of profitability, EMLAF's ROE is +0.12%, compared to SVNDF's ROE of +0.08%. Regarding short-term risk, EMLAF and SVNDF have similar daily volatility (0.00).Check SVNDF's competition here
EMLAF vs SVNDY Comparison February 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.4B. In comparison, SVNDY has a market cap of 34.3B. Regarding current trading prices, EMLAF is priced at $36.29, while SVNDY trades at $14.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 16.72, whereas SVNDY's P/E ratio is 23.24. In terms of profitability, EMLAF's ROE is +0.12%, compared to SVNDY's ROE of +0.08%. Regarding short-term risk, EMLAF is less volatile compared to SVNDY. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check SVNDY's competition here
EMLAF vs WNGRF Comparison February 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.4B. In comparison, WNGRF has a market cap of 27.8B. Regarding current trading prices, EMLAF is priced at $36.29, while WNGRF trades at $72.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 16.72, whereas WNGRF's P/E ratio is 26.41. In terms of profitability, EMLAF's ROE is +0.12%, compared to WNGRF's ROE of +0.26%. Regarding short-term risk, EMLAF and WNGRF have similar daily volatility (0.00).Check WNGRF's competition here
EMLAF vs WOLWF Comparison February 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.4B. In comparison, WOLWF has a market cap of 25.6B. Regarding current trading prices, EMLAF is priced at $36.29, while WOLWF trades at $20.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 16.72, whereas WOLWF's P/E ratio is 38.07. In terms of profitability, EMLAF's ROE is +0.12%, compared to WOLWF's ROE of +0.19%. Regarding short-term risk, EMLAF and WOLWF have similar daily volatility (0.00).Check WOLWF's competition here
EMLAF vs CLEGF Comparison February 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.4B. In comparison, CLEGF has a market cap of 22.5B. Regarding current trading prices, EMLAF is priced at $36.29, while CLEGF trades at $16.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 16.72, whereas CLEGF's P/E ratio is 29.47. In terms of profitability, EMLAF's ROE is +0.12%, compared to CLEGF's ROE of +0.29%. Regarding short-term risk, EMLAF and CLEGF have similar daily volatility (0.00).Check CLEGF's competition here
EMLAF vs KKOYY Comparison February 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.4B. In comparison, KKOYY has a market cap of 19.6B. Regarding current trading prices, EMLAF is priced at $36.29, while KKOYY trades at $12.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 16.72, whereas KKOYY's P/E ratio is 20.56. In terms of profitability, EMLAF's ROE is +0.12%, compared to KKOYY's ROE of +0.15%. Regarding short-term risk, EMLAF is less volatile compared to KKOYY. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check KKOYY's competition here
EMLAF vs MTRAF Comparison February 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.4B. In comparison, MTRAF has a market cap of 15.5B. Regarding current trading prices, EMLAF is priced at $36.29, while MTRAF trades at $71.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 16.72, whereas MTRAF's P/E ratio is 21.90. In terms of profitability, EMLAF's ROE is +0.12%, compared to MTRAF's ROE of +0.14%. Regarding short-term risk, EMLAF is less volatile compared to MTRAF. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check MTRAF's competition here
EMLAF vs CVPBF Comparison February 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.4B. In comparison, CVPBF has a market cap of 15.1B. Regarding current trading prices, EMLAF is priced at $36.29, while CVPBF trades at $1.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 16.72, whereas CVPBF's P/E ratio is 16.83. In terms of profitability, EMLAF's ROE is +0.12%, compared to CVPBF's ROE of +0.22%. Regarding short-term risk, EMLAF and CVPBF have similar daily volatility (0.00).Check CVPBF's competition here
EMLAF vs CRRFY Comparison February 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.4B. In comparison, CRRFY has a market cap of 13.5B. Regarding current trading prices, EMLAF is priced at $36.29, while CRRFY trades at $3.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 16.72, whereas CRRFY's P/E ratio is 34.82. In terms of profitability, EMLAF's ROE is +0.12%, compared to CRRFY's ROE of +0.03%. Regarding short-term risk, EMLAF is less volatile compared to CRRFY. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check CRRFY's competition here
EMLAF vs CRERF Comparison February 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.4B. In comparison, CRERF has a market cap of 12.8B. Regarding current trading prices, EMLAF is priced at $36.29, while CRERF trades at $18.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 16.72, whereas CRERF's P/E ratio is 32.98. In terms of profitability, EMLAF's ROE is +0.12%, compared to CRERF's ROE of +0.03%. Regarding short-term risk, EMLAF and CRERF have similar daily volatility (0.00).Check CRERF's competition here
EMLAF vs CPPCY Comparison February 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.4B. In comparison, CPPCY has a market cap of 12B. Regarding current trading prices, EMLAF is priced at $36.29, while CPPCY trades at $13.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 16.72, whereas CPPCY's P/E ratio is 13.79. In terms of profitability, EMLAF's ROE is +0.12%, compared to CPPCY's ROE of +0.22%. Regarding short-term risk, EMLAF and CPPCY have similar daily volatility (0.00).Check CPPCY's competition here
EMLAF vs CVPUF Comparison February 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.4B. In comparison, CVPUF has a market cap of 11.6B. Regarding current trading prices, EMLAF is priced at $36.29, while CVPUF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 16.72, whereas CVPUF's P/E ratio is 13.00. In terms of profitability, EMLAF's ROE is +0.12%, compared to CVPUF's ROE of +0.22%. Regarding short-term risk, EMLAF and CVPUF have similar daily volatility (0.00).Check CVPUF's competition here
EMLAF vs DNOPY Comparison February 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.4B. In comparison, DNOPY has a market cap of 11.4B. Regarding current trading prices, EMLAF is priced at $36.29, while DNOPY trades at $11.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 16.72, whereas DNOPY's P/E ratio is 25.20. In terms of profitability, EMLAF's ROE is +0.12%, compared to DNOPY's ROE of +0.21%. Regarding short-term risk, EMLAF is less volatile compared to DNOPY. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check DNOPY's competition here
EMLAF vs JSAIY Comparison February 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.4B. In comparison, JSAIY has a market cap of 11.3B. Regarding current trading prices, EMLAF is priced at $36.29, while JSAIY trades at $19.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 16.72, whereas JSAIY's P/E ratio is 19.87. In terms of profitability, EMLAF's ROE is +0.12%, compared to JSAIY's ROE of +0.05%. Regarding short-term risk, EMLAF is less volatile compared to JSAIY. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check JSAIY's competition here
EMLAF vs JSNSF Comparison February 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.4B. In comparison, JSNSF has a market cap of 10.8B. Regarding current trading prices, EMLAF is priced at $36.29, while JSNSF trades at $4.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 16.72, whereas JSNSF's P/E ratio is 19.48. In terms of profitability, EMLAF's ROE is +0.12%, compared to JSNSF's ROE of +0.05%. Regarding short-term risk, EMLAF and JSNSF have similar daily volatility (0.00).Check JSNSF's competition here
EMLAF vs KKOYF Comparison February 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.4B. In comparison, KKOYF has a market cap of 8.1B. Regarding current trading prices, EMLAF is priced at $36.29, while KKOYF trades at $20.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 16.72, whereas KKOYF's P/E ratio is 18.90. In terms of profitability, EMLAF's ROE is +0.12%, compared to KKOYF's ROE of +0.15%. Regarding short-term risk, EMLAF and KKOYF have similar daily volatility (0.00).Check KKOYF's competition here
EMLAF vs BMBRF Comparison February 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.4B. In comparison, BMBRF has a market cap of 6.8B. Regarding current trading prices, EMLAF is priced at $36.29, while BMBRF trades at $11.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 16.72, whereas BMBRF's P/E ratio is 16.91. In terms of profitability, EMLAF's ROE is +0.12%, compared to BMBRF's ROE of +0.11%. Regarding short-term risk, EMLAF and BMBRF have similar daily volatility (0.00).Check BMBRF's competition here
EMLAF vs GCHEF Comparison February 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.4B. In comparison, GCHEF has a market cap of 6.3B. Regarding current trading prices, EMLAF is priced at $36.29, while GCHEF trades at $6.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 16.72, whereas GCHEF's P/E ratio is 16.45. In terms of profitability, EMLAF's ROE is +0.12%, compared to GCHEF's ROE of +0.13%. Regarding short-term risk, EMLAF and GCHEF have similar daily volatility (0.00).Check GCHEF's competition here
EMLAF vs AXFOY Comparison February 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.4B. In comparison, AXFOY has a market cap of 5.9B. Regarding current trading prices, EMLAF is priced at $36.29, while AXFOY trades at $27.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 16.72, whereas AXFOY's P/E ratio is 26.71. In terms of profitability, EMLAF's ROE is +0.12%, compared to AXFOY's ROE of +0.35%. Regarding short-term risk, EMLAF and AXFOY have similar daily volatility (0.00).Check AXFOY's competition here
EMLAF vs DFILF Comparison February 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.4B. In comparison, DFILF has a market cap of 5.7B. Regarding current trading prices, EMLAF is priced at $36.29, while DFILF trades at $4.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 16.72, whereas DFILF's P/E ratio is -14.96. In terms of profitability, EMLAF's ROE is +0.12%, compared to DFILF's ROE of -0.62%. Regarding short-term risk, EMLAF and DFILF have similar daily volatility (0.00).Check DFILF's competition here
EMLAF vs KOBNF Comparison February 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.4B. In comparison, KOBNF has a market cap of 5.3B. Regarding current trading prices, EMLAF is priced at $36.29, while KOBNF trades at $24.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 16.72, whereas KOBNF's P/E ratio is 26.48. In terms of profitability, EMLAF's ROE is +0.12%, compared to KOBNF's ROE of +0.21%. Regarding short-term risk, EMLAF and KOBNF have similar daily volatility (0.00).Check KOBNF's competition here
EMLAF vs CUYTF Comparison February 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.4B. In comparison, CUYTF has a market cap of 5.3B. Regarding current trading prices, EMLAF is priced at $36.29, while CUYTF trades at $44.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 16.72, whereas CUYTF's P/E ratio is 14.65. In terms of profitability, EMLAF's ROE is +0.12%, compared to CUYTF's ROE of +0.09%. Regarding short-term risk, EMLAF and CUYTF have similar daily volatility (0.00).Check CUYTF's competition here
EMLAF vs AXFOF Comparison February 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.4B. In comparison, AXFOF has a market cap of 5.2B. Regarding current trading prices, EMLAF is priced at $36.29, while AXFOF trades at $24.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 16.72, whereas AXFOF's P/E ratio is 23.34. In terms of profitability, EMLAF's ROE is +0.12%, compared to AXFOF's ROE of +0.36%. Regarding short-term risk, EMLAF and AXFOF have similar daily volatility (0.00).Check AXFOF's competition here
EMLAF vs DFIHY Comparison February 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.4B. In comparison, DFIHY has a market cap of 4.5B. Regarding current trading prices, EMLAF is priced at $36.29, while DFIHY trades at $16.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 16.72, whereas DFIHY's P/E ratio is -11.97. In terms of profitability, EMLAF's ROE is +0.12%, compared to DFIHY's ROE of -0.62%. Regarding short-term risk, EMLAF and DFIHY have similar daily volatility (0.00).Check DFIHY's competition here
EMLAF vs CUYTY Comparison February 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.4B. In comparison, CUYTY has a market cap of 4.3B. Regarding current trading prices, EMLAF is priced at $36.29, while CUYTY trades at $9.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 16.72, whereas CUYTY's P/E ratio is 12.99. In terms of profitability, EMLAF's ROE is +0.12%, compared to CUYTY's ROE of +0.09%. Regarding short-term risk, EMLAF and CUYTY have similar daily volatility (0.00).Check CUYTY's competition here
EMLAF vs SHUFF Comparison February 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.4B. In comparison, SHUFF has a market cap of 3.4B. Regarding current trading prices, EMLAF is priced at $36.29, while SHUFF trades at $12.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 16.72, whereas SHUFF's P/E ratio is 16.04. In terms of profitability, EMLAF's ROE is +0.12%, compared to SHUFF's ROE of +0.17%. Regarding short-term risk, EMLAF and SHUFF have similar daily volatility (0.00).Check SHUFF's competition here
EMLAF vs OCDDY Comparison February 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.4B. In comparison, OCDDY has a market cap of 2.6B. Regarding current trading prices, EMLAF is priced at $36.29, while OCDDY trades at $6.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 16.72, whereas OCDDY's P/E ratio is -5.20. In terms of profitability, EMLAF's ROE is +0.12%, compared to OCDDY's ROE of +0.08%. Regarding short-term risk, EMLAF and OCDDY have similar daily volatility (0.00).Check OCDDY's competition here
EMLAF vs OCDGF Comparison February 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.4B. In comparison, OCDGF has a market cap of 2.5B. Regarding current trading prices, EMLAF is priced at $36.29, while OCDGF trades at $2.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 16.72, whereas OCDGF's P/E ratio is -4.81. In terms of profitability, EMLAF's ROE is +0.12%, compared to OCDGF's ROE of +0.29%. Regarding short-term risk, EMLAF and OCDGF have similar daily volatility (0.00).Check OCDGF's competition here
EMLAF vs GGGSY Comparison February 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.4B. In comparison, GGGSY has a market cap of 2.3B. Regarding current trading prices, EMLAF is priced at $36.29, while GGGSY trades at $7.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 16.72, whereas GGGSY's P/E ratio is 11.56. In terms of profitability, EMLAF's ROE is +0.12%, compared to GGGSY's ROE of +0.25%. Regarding short-term risk, EMLAF and GGGSY have similar daily volatility (0.00).Check GGGSY's competition here
EMLAF vs GGGSF Comparison February 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.4B. In comparison, GGGSF has a market cap of 2.3B. Regarding current trading prices, EMLAF is priced at $36.29, while GGGSF trades at $22.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 16.72, whereas GGGSF's P/E ratio is 11.53. In terms of profitability, EMLAF's ROE is +0.12%, compared to GGGSF's ROE of +0.25%. Regarding short-term risk, EMLAF is less volatile compared to GGGSF. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check GGGSF's competition here
EMLAF vs NNWWF Comparison February 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.4B. In comparison, NNWWF has a market cap of 2B. Regarding current trading prices, EMLAF is priced at $36.29, while NNWWF trades at $41.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 16.72, whereas NNWWF's P/E ratio is 19.00. In terms of profitability, EMLAF's ROE is +0.12%, compared to NNWWF's ROE of +0.18%. Regarding short-term risk, EMLAF and NNWWF have similar daily volatility (0.00).Check NNWWF's competition here
EMLAF vs CGUSY Comparison February 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.4B. In comparison, CGUSY has a market cap of 1.7B. Regarding current trading prices, EMLAF is priced at $36.29, while CGUSY trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 16.72, whereas CGUSY's P/E ratio is -0.00. In terms of profitability, EMLAF's ROE is +0.12%, compared to CGUSY's ROE of -33.50%. Regarding short-term risk, EMLAF and CGUSY have similar daily volatility (0.00).Check CGUSY's competition here
EMLAF vs RLEVF Comparison February 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.4B. In comparison, RLEVF has a market cap of 1B. Regarding current trading prices, EMLAF is priced at $36.29, while RLEVF trades at $74.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 16.72, whereas RLEVF's P/E ratio is 15.38. In terms of profitability, EMLAF's ROE is +0.12%, compared to RLEVF's ROE of +0.40%. Regarding short-term risk, EMLAF and RLEVF have similar daily volatility (0.00).Check RLEVF's competition here
EMLAF vs EUSHY Comparison February 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.4B. In comparison, EUSHY has a market cap of 267.9M. Regarding current trading prices, EMLAF is priced at $36.29, while EUSHY trades at $1.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 16.72, whereas EUSHY's P/E ratio is -38.50. In terms of profitability, EMLAF's ROE is +0.12%, compared to EUSHY's ROE of -0.04%. Regarding short-term risk, EMLAF and EUSHY have similar daily volatility (0.00).Check EUSHY's competition here
EMLAF vs EUSHF Comparison February 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.4B. In comparison, EUSHF has a market cap of 238M. Regarding current trading prices, EMLAF is priced at $36.29, while EUSHF trades at $1.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 16.72, whereas EUSHF's P/E ratio is -10.69. In terms of profitability, EMLAF's ROE is +0.12%, compared to EUSHF's ROE of -0.04%. Regarding short-term risk, EMLAF and EUSHF have similar daily volatility (0.00).Check EUSHF's competition here
EMLAF vs CGUIF Comparison February 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.4B. In comparison, CGUIF has a market cap of 91M. Regarding current trading prices, EMLAF is priced at $36.29, while CGUIF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 16.72, whereas CGUIF's P/E ratio is -0.03. In terms of profitability, EMLAF's ROE is +0.12%, compared to CGUIF's ROE of -0.50%. Regarding short-term risk, EMLAF and CGUIF have similar daily volatility (0.00).Check CGUIF's competition here
EMLAF vs HCMC Comparison February 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.4B. In comparison, HCMC has a market cap of 24.1M. Regarding current trading prices, EMLAF is priced at $36.29, while HCMC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 16.72, whereas HCMC's P/E ratio is N/A. In terms of profitability, EMLAF's ROE is +0.12%, compared to HCMC's ROE of +3.06%. Regarding short-term risk, EMLAF is less volatile compared to HCMC. This indicates potentially lower risk in terms of short-term price fluctuations for EMLAF.Check HCMC's competition here
EMLAF vs FLOCF Comparison February 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.4B. In comparison, FLOCF has a market cap of 6.2M. Regarding current trading prices, EMLAF is priced at $36.29, while FLOCF trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 16.72, whereas FLOCF's P/E ratio is -0.25. In terms of profitability, EMLAF's ROE is +0.12%, compared to FLOCF's ROE of +2.82%. Regarding short-term risk, EMLAF and FLOCF have similar daily volatility (0.00).Check FLOCF's competition here
EMLAF vs IFMK Comparison February 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.4B. In comparison, IFMK has a market cap of 1.9M. Regarding current trading prices, EMLAF is priced at $36.29, while IFMK trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 16.72, whereas IFMK's P/E ratio is -0.33. In terms of profitability, EMLAF's ROE is +0.12%, compared to IFMK's ROE of +4.63%. Regarding short-term risk, EMLAF and IFMK have similar daily volatility (0.00).Check IFMK's competition here
EMLAF vs MTVX Comparison February 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.4B. In comparison, MTVX has a market cap of 822.8K. Regarding current trading prices, EMLAF is priced at $36.29, while MTVX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 16.72, whereas MTVX's P/E ratio is N/A. In terms of profitability, EMLAF's ROE is +0.12%, compared to MTVX's ROE of +0.39%. Regarding short-term risk, EMLAF and MTVX have similar daily volatility (0.00).Check MTVX's competition here
EMLAF vs OMHI Comparison February 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.4B. In comparison, OMHI has a market cap of 20.9K. Regarding current trading prices, EMLAF is priced at $36.29, while OMHI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 16.72, whereas OMHI's P/E ratio is 0.01. In terms of profitability, EMLAF's ROE is +0.12%, compared to OMHI's ROE of +0.15%. Regarding short-term risk, EMLAF and OMHI have similar daily volatility (0.00).Check OMHI's competition here
EMLAF vs HWIN Comparison February 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.4B. In comparison, HWIN has a market cap of 3.6K. Regarding current trading prices, EMLAF is priced at $36.29, while HWIN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 16.72, whereas HWIN's P/E ratio is N/A. In terms of profitability, EMLAF's ROE is +0.12%, compared to HWIN's ROE of -0.37%. Regarding short-term risk, EMLAF and HWIN have similar daily volatility (0.00).Check HWIN's competition here
EMLAF vs MFLTY Comparison February 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.4B. In comparison, MFLTY has a market cap of 2.3K. Regarding current trading prices, EMLAF is priced at $36.29, while MFLTY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 16.72, whereas MFLTY's P/E ratio is N/A. In terms of profitability, EMLAF's ROE is +0.12%, compared to MFLTY's ROE of +1.75%. Regarding short-term risk, EMLAF and MFLTY have similar daily volatility (0.00).Check MFLTY's competition here
EMLAF vs QKLS Comparison February 2026
EMLAF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMLAF stands at 8.4B. In comparison, QKLS has a market cap of 152. Regarding current trading prices, EMLAF is priced at $36.29, while QKLS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMLAF currently has a P/E ratio of 16.72, whereas QKLS's P/E ratio is N/A. In terms of profitability, EMLAF's ROE is +0.12%, compared to QKLS's ROE of -2.85%. Regarding short-term risk, EMLAF and QKLS have similar daily volatility (0.00).Check QKLS's competition here